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Genetic association studies have been a popular approach for as-
sessing the association between common Single Nucleotide Polymor-
phisms (SNPs) and complex diseases. However, other genomic data
involved in the mechanism from SNPs to disease, for example, gene
expressions, are usually neglected in these association studies. In this
paper, we propose to exploit gene expression information to more
powerfully test the association between SNPs and diseases by jointly
modeling the relations among SNPs, gene expressions and diseases.
We propose a variance component test for the total effect of SNPs
and a gene expression on disease risk. We cast the test within the
causal mediation analysis framework with the gene expression as a
potential mediator. For eQTL SNPs, the use of gene expression in-
formation can enhance power to test for the total effect of a SNP-set,
which is the combined direct and indirect effects of the SNPs medi-
ated through the gene expression, on disease risk. We show that the
test statistic under the null hypothesis follows a mixture of χ2 distri-
butions, which can be evaluated analytically or empirically using the
resampling-based perturbation method. We construct tests for each
of three disease models that are determined by SNPs only, SNPs and
gene expression, or include also their interactions. As the true dis-
ease model is unknown in practice, we further propose an omnibus
test to accommodate different underlying disease models. We eval-
uate the finite sample performance of the proposed methods using
simulation studies, and show that our proposed test performs well
and the omnibus test can almost reach the optimal power where the
disease model is known and correctly specified. We apply our method
to reanalyze the overall effect of the SNP-set and expression of the
ORMDL3 gene on the risk of asthma.
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1. Introduction. Genome-wide association studies (GWAS) constitute
a popular approach for investigating the association of common Single Nu-
cleotide Polymorphisms (SNPs) with complex diseases. Usually, a large num-
ber of SNP markers are tested across the genome. Great interest lies in
improving power of testing SNP effects by borrowing additional biological
information. Indeed, a major criticism of genetic association studies lies in
its agnostic style [Hunter and Chanock (2010)]: none of the biological knowl-
edge was encoded in the standard genetic association analyses. To overcome
such limitations, multi-marker analysis has been advocated to integrate bi-
ological information into statistical analyses and to decrease the number of
tests [Kwee et al. (2008); Wu et al. (2010)]. Analysis using SNP-sets grouped
by physical locations has better performance than the standard single SNP
analysis in reanalyzing the breast cancer GWAS data [Wu et al. (2010)].
SNPs can also be grouped into a SNP-set according to biological pathways,
in which a gene harmonizes with other genes to exert biological functions.
The two factors we try to bridge in genetic association studies are SNPs
and disease risk. Despite the success of SNP-set analyses in assembling mul-
tiple SNPs based on biological information, mechanistic pathways between
SNPs (SNP-sets) and disease are still neglected. Given the availability of
multiple sources in genomic data (e.g., gene expression and SNPs) [Moffatt
et al. (2007); Cusanovich et al. (2012)], it is desirable to perform joint anal-
ysis by integrating multiple sources of genomic data. Here we combine the
information of SNPs and gene expression by introducing gene expression as
a mediator in the causal pathway from SNPs to disease. Biologically, gene
expression can be determined by the DNA genotype [Morley et al. (2004);
Cheung et al. (2005); Fu et al. (2009)] and that gene expression can also
affect disease risk [Dermitzakis (2008)]. Moreover, results from the SNP-set
analysis augmented by a biological model can be more scientifically mean-
ingful. Statistically, gene expression can help explain variability of the effect
of SNPs on disease when there exists an effect of SNPs on disease via gene
expression and thus increases the power of detecting the overall effect of
SNPs on disease risk.
SNPs that regulate mRNA expression of a gene are so-called expression
Quantitative Trait Loci (eQTL) [Schadt et al. (2003)]. Statistically, eQTL
SNPs can be viewed as the SNPs that are correlated with mRNA expres-
sion of a gene. Cis-eQTL SNPs are the SNPs that are within or around the
corresponding gene, and trans-eQTL SNPs are those that are far away or
even on different chromosomes. Numerous genome-wide eQTL analyses have
been reported to comprehensively capture such a DNA–RNA (i.e., SNPs-
gene expression) association in the genome in different tissues and organisms
[Schadt et al. (2003); Morley et al. (2004); Innocenti et al. (2011)]. eQTL
results can be external information to prioritize the discovery of susceptibil-
ity loci in genome-wide association studies [Hsu et al. (2010); Zhong et al.
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(2010); Zhang et al. (2012)]. Methods are available to integrate multiple ge-
nomic data to draw causal inference on a biological network [Schadt et al.
(2005); Zhu et al. (2008); Hageman et al. (2011); Neto et al. (2013)]. We
focus in this paper on joint analysis of multiple eQTL SNPs of a gene and
their corresponding mRNA expression for their effects on disease pheno-
types. Compared with multi-SNP analyses, this approach further incorpo-
rates eQTLs into genetic association studies and accounts for a biological
process (from DNA to RNA) within a gene to improve power.
This paper is motivated by an asthma genome-wide association study
of subjects of British descent (MRC-A), in which the association between
SNPs at the ORMDL3 gene and the risk of childhood asthma was inves-
tigated [Dixon et al. (2007); Moffatt et al. (2007)]. The MRC-A data set
consists of 108 cases and 50 controls with both SNP genotype (Illumina
300K) and gene expression (Affymetrix HU133A 2.0) data available. The
original genome-wide study reported that the 10 typed SNPs on chromo-
some 17q21 where ORMDL3 is located were strongly associated with child-
hood asthma in MRC-A data, and the results were validated in several other
independent studies. The authors also found that each of these 10 SNPs was
highly correlated with gene expression of ORMDL3, which is also associ-
ated with asthma. The 10 SNPs, ORMDL3 expression and asthma status
can be illustrated as the S, G and Y , respectively, in Figure 1. Instead of
analyzing SNP-expression, expression-asthma and SNP-asthma associations
separately and univariately, here we are interested in assessing the overall
genetic effect of ORMDL3 on the occurrence of childhood asthma, by jointly
analyzing SNP and gene expression data and accounting for the possibility
that the ORMDL3 gene expression might be a causal mediator for the as-
sociation of the SNPs in the ORMDL3 gene and asthma risk. Our ultimate
goal is to integrate multiple sources of genomic data for genetic association
analyses.
In this paper we propose to jointly model a set of SNPs within a gene, a
gene expression and disease status, where a logistic model is used to model
Fig. 1. Causal diagram of the mediation model. S is a set of correlated exposures, for
example, SNP set; G is a mediator, for example, gene expression; Y is an outcome, for
example, disease (yes/no); and X are covariates, including the true and potential con-
founders.
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the dependence of disease status on the SNP-set and the gene expression,
and a linear model is used for the dependence of the gene expression on the
SNP-set, both adjusting for covariates. We are primarily interested in testing
whether a gene, whose effects are captured by SNPs and/or gene expression,
is associated with a disease phenotype. We formulate this hypothesis in
the causal mediation analysis framework [Robins and Greenland (1992);
VanderWeele and Vansteelandt (2009, 2010); Imai, Keele and Yamamoto
(2010)]. Note that the previous work on causal mediation analysis is mostly
focused on estimation.
We use the joint model to derive the direct and indirect effects of a SNP-
set mediated through gene expression on disease risk. For eQTL SNPs, we
show that the total effect of a gene on a disease captured by a set of SNPs and
a gene expression corresponds to the total effects of the SNP-set, which are
the combined direct effects and indirect effects of the SNPs mediated through
the gene expression, on a disease. This framework allows us to study how
the use of gene expression data can enhance power to test for the total effect
of a SNP-set on disease risk. We study the impact of model misspecification
using the conventional SNP-only models when the true model is that both
the SNPs and the gene expression affect the disease outcome. For non-eQTL
SNPs, the null hypothesis simply corresponds to the joint effects of the SNPs
and the gene expression.
Due to a potentially large number of SNPs within a gene and some of
them possibly being highly correlated, that is, in high linkage disequilibrium
(LD), conventional tests, such as the likelihood ratio test, for the total effects
of multiple SNPs and a gene expression, do not perform well. We propose
in this paper a variance component test to assess the overall effects of a
SNP set and a gene expression on disease risk, under the null that the test
statistic follows a mixture of χ2 distributions, which can be approximated
analytically or empirically using a resampling-based perturbation procedure
[Parzen, Wei and Ying (1994); Cai, Lin and Carroll (2012)]. As the true
disease model is often unknown, we construct an omnibus test to improve
the power by accommodating different underlying disease models.
The rest of the paper is organized as follows. In Section 2 we introduce
the joint model for SNPs, a gene expression and disease as well as the null
hypothesis of no joint effect of the SNPs and the gene expression on a disease
phenotype. In Section 3 we propose a variance component score test for the
total effect of SNPs and gene expression, and construct an omnibus test
to maximize the test power across different underlying disease models. In
Section 4 we interpret the null hypothesis and study the assumptions within
the framework of causal mediation modeling for eQTL SNPs and non-eQTL
SNPs. In Section 5 we evaluate the finite sample performance of the proposed
test using simulation studies and show that the omnibus test is robust and
performs well in different situations. In Section 6 we apply the proposed
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method to study the overall effect of the ORMDL3 gene contributed by
both the SNPs and the gene expression on the risk of childhood asthma,
followed by discussions in Section 7.
2. The model and the null hypothesis. The statistical problem is to
jointly model the effect of a set of SNPs and a gene expression on the occur-
rence of a disease. Assume for subject i (i= 1, . . . , n) an outcome of interest
Yi is dichotomous (e.g., case/control), whose mean is associated with q co-
variates (Xi, with the first covariate to be 1, i.e., the intercept), p SNPs in a
SNP-set (Si), mRNA expression of a gene (Gi) and possibly the interactions
between the SNPs and the gene expression as
logit{P (Yi = 1|Si,Gi,Xi)}=XTi α+ STi βS +GiβG +GiSTi γ,(2.1)
where α= (α1, . . . , αq)
T ,βS = (βS1 , . . . , βSp)
T , βG, and γ = (γ1, . . . , γp)
T are
the regression coefficients for the covariates, the SNPs, the gene expression,
and the interactions of the SNPs and the gene expression, respectively. A
SNP-set and gene expression pair can be defined in multiple ways. For exam-
ple, S can be the SNPs in a gene and G is the mRNA expression of the gene.
In the asthma data example, S are the 10 typed SNPs around ORMDL3
and G is the expression of ORMDL3. Alternatively, one can choose the SNP-
set/expression pair based on the eQTL study: eQTL SNP-set/corresponding
gene expression.
As SNPs can affect gene expression [Schadt et al. (2003); Morley et al.
(2004); Innocenti et al. (2011)], for each subject i, we next consider a lin-
ear model for the continuous gene expression Gi (i.e., the mediator), which
depends on the q covariates (Xi) and the p SNPs (Si):
Gi =X
T
i φ+S
T
i δ + εi,(2.2)
where φ= (φ1, . . . , φq)
T and δ = (δ1, . . . , δp)
T are the regression coefficients
for the covariates and the SNPs, respectively, and εi follows a normal distri-
bution with mean 0 and variance σ2G. Again, the p SNPs can be the SNPs
within a gene or the eQTL SNPs corresponding to a gene for which the
expression level is measured.
Our goal is to test for the total effect of a gene captured by the SNPs
in a set S and a gene expression G on Y , which can be written using the
regression coefficients in model (2.1) as
H0 :βS = 0, βG = 0, γ = 0.(2.3)
Note that the null hypothesis (2.3) only involves the parameters in the
[Y |S,G,X] model (2.1). We use the [G|S,X] model in Section 4 to facili-
tate interpretation of the null hypothesis (2.3) and to study the assumptions
within the causal mediation analysis framework. Throughout the paper, we
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term this null hypothesis as a test for the total effect of a gene. Later, in Sec-
tion 4 we will show that it corresponds to the total effect of SNPs for eQTL
SNPs and simply to the joint effect of SNPs and expression for non-eQTL
SNPs.
3. Test for the total effects of a gene.
3.1. Test statistic for the total effect of a gene. We propose in this section
to test for the null hypothesis of no total effect of a gene (2.3) under model
(2.1). As the number of SNPs (p) in a gene might be large and some might
be highly correlated (due to linkage disequilibrium), the likelihood ratio test
(LRT) or multivariate Wald test for the null hypothesis (2.3) uses a large
degree of freedom (DF) and has limited power. To overcome this problem, we
assume under model (2.1) the regression coefficients of the individual main
SNP effects βSj are independent and follow an arbitrary distribution with
mean 0 and variance τS , and the SNP-by-expression interaction coefficients
γj (j = 1, . . . , p) are independent and follow another arbitrary distribution
with mean 0 and variance τI . The resulting outcome model (2.1) hence
becomes a logistic mixed model. The problem for testing the null hypothesis
(2.3) becomes a joint test of variance components (τS = τI = 0) and the
scalar regression coefficient for the fixed gene expression effect (βG = 0) in
the induced logistic mixed models as H0 : τS = τI = 0 and βG = 0. One can
easily show that the scores for τS , βG and τI under the induced logistic
mixed models are
UτS = {Y− µˆ0}TSST {Y− µˆ0}, UβG =GT {Y− µˆ0},
UτI = {Y− µˆ0}TCCT {Y− µˆ0},
where Y = (Y1, Y2, . . . , Yn)
T , X = (X1,X2, . . . ,Xn)
T , S = (S1,S2, . . . ,Sn)
T ,
G = (G1,G2, . . . ,Gn)
T and C = (C1,C2, . . . ,Cn)
T = (G1S1,G2S2, . . . ,
GnSn)
T ; µˆ0 = (µˆ01, . . . , µˆ0n)
T and µˆ0i = exp(X
T
i αˆ0)/{1 + exp(XTi αˆ0)} is
the mean of Yi under H0, and αˆ0 is the maximum likelihood estimator of α
under the null model
logit{P (Yi = 1|Si,Gi,Xi)}=XTi α.(3.1)
To combine the three scores to test for the null hypothesis H0 : τS = τI =
0 and βG = 0, one may consider the conventional score statistic Qconv =
U
T I−1U, where U= (UτS ,UβG ,UτI )T and I is the efficient information ma-
trix of U. However, this approach has several major limitations. First, notice
that the score of the regression coefficient of gene expression UβG is a linear
function of Y , while the scores of the variance components of main effects
of SNPs and SNP-by-expression interactions τS and τI are quadratic func-
tions of Y . Hence, UβG has a different scale from (UτS ,UτI ). It follows that
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(UτS ,UτI ) are likely to dominate UβG . A combination of the three scores
using Qconv is hence not desirable. Second, Qconv involves quartic functions
of Y and the information matrix I involves the 8th moment of Y. Hence,
calculations of Qconv are not stable, and it is difficult to analytically approx-
imate the null distribution of Qconv.
We hence propose the following weighted sum of three scores as the test
statistic for the null hypothesis (2.3):
Q= n−1(a1UτS + a2U
2
βG
+ a3UτI )
(3.2)
= n−1(Y− µˆ0)T (a1SST + a2GGT + a3CCT )(Y− µˆ0),
where a1, a2, a3 are some weights. Q is a nice quadratic function of Y. Hence,
its null distribution can be easily approximated by a mixture of χ2 distribu-
tions. Different weights can be chosen. With an equal weight a1 = a2 = a3,
Q is equivalent to the variance component test for τcommon by assuming
βSj , βG and γj follow a common distribution with mean zero and variance
τcommon. However, this common distribution assumption is strong, as S, G
and C generally have different scales and so do their effects βSj , βG and γj .
Notice that UτS ,U
2
βG
,UτI are all quadratic functions of Y in similar forms;
we propose to weight each term UτS ,U
2
βG
,UτI using the inverse of the square
root of their corresponding variances. This allows each weighted term to have
variance 1 and be comparable. Specifically, the variances for UτS ,U
2
βG
,UτI
are IτS = 1
T (SST ·K ·SST )1, IG = 1T (GGT ·K ·GGT )1, IτI = 1T (CCT ·K ·
CC
T )1, respectively, where A ·B denotes the component-wise multiplication
of conformable matrices A and B, 1 denotes a vector of ones, the diagonal
and off-diagonal elements of K are kii =−4µˆ40i+8µˆ30i− 5µ20i+ µˆ0i and kii′ =
2[µˆ0i(1− µˆ0i)][µˆ0i′(1− µˆ0i′)], respectively [Lin (1997)].
We derive the asymptotic distribution of Q under the null hypothesis
(2.3) by accounting Q = Q(αˆ) is a function of αˆ, which is the maximum
likelihood estimate of α under the null model (3.1). Define
D=
[
DXX DXV
DV X DV V
]
= n−1UTWU,
whereU= (U1,U2, . . . ,Un)
T ,Ui = (X
T
i ,V
T
i ),V
T
i = (
√
a1S
T
i ,
√
a2Gi,
√
a3C
T
i ),
W= diag{µi(1−µi)}. We show in Section 3 of the supplementary material
[Huang, VanderWeele and Lin (2013)] that under the null hypothesis (2.3),
the score test statistic Q converges in distribution to Q(0) =
∑2p+1
l=1 (A
T
l ε)
2,
where ε is a random vector following N(0, D) and Al is the lth row of
A = [−DTXVD−1XX , I(2p+1)×(2p+1)]. This means under the null hypothesis Q
follows a mixture of χ2 distributions, which can be approximated using a
scaled χ2 distribution by matching the first two moments [Satterthwaite
(1946)] as Q
.∼ κχ2ν , where κ = Var(Q)/[2E(Q)] and ν = 2[E(Q)]2/Var(Q),
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and the expressions of E(Q) and Var(Q) are given in Section 3 of the sup-
plementary material [Huang, VanderWeele and Lin (2013)]. Alternatively,
one can approximate the mixture of χ2 distribution using the characteristic
function inversion method [Davies (1980)].
3.2. The omnibus test for the total effect of a gene. So far we derive the
test statistic Q under the outcome model specified in (2.1), which assumes
the disease risk of Y depends on SNPs, gene expression and their interac-
tions. Denote this Q by QSGC . Suppose that the disease risk of Y depends
on SNPs and gene expression but not their interactions, or even depends
only on SNPs, then it is more powerful to test for the total SNP effect us-
ing the test statistics QSG = n
−1(Y− µˆ0)T (a1SST + a2GGT )(Y − µˆ0) and
QS = n
−1(Y− µˆ0)T (a1SST )(Y− µˆ0), respectively. Under these simpler dis-
ease models, the test statistic QSGC loses power as it tests for extra unnec-
essary parameters. On the other hand, if the disease risk indeed depends on
SNPs, expression and their interactions, performing tests only using SNPs
QS or main effects QSG will lose power, compared to QSGC .
Since in reality we do not know the underlying true disease model, it is
difficult to choose a correct model. It is hence desirable to develop a test that
can accommodate different disease models to maximize the power. Moreover,
in a genome-wide association study, it is almost impossible that one disease
model is true for tens of thousands of genes. Thus, we further propose an
omnibus test where we identify the strongest evidence among the three dif-
ferent models with: (1) only SNPs, (2) SNPs and gene expression, and (3)
SNPs, gene expression and their interactions. Specifically, we calculate the
p-value under each of the three models, then compute the minimum of the
three p-values and compare the observed minimum p-value to its null dis-
tribution. Because of the complicated correlation among QSGC , QSG and
QS , it is difficult to analytically derive the null distribution of the minimum
p-value. To this end, we resort to a resampling perturbation procedure.
As shown in Section 3.1,Q converges in distribution toQ(0) =
∑2p+1
l=1 (A
T
l ε)
2.
The empirical distribution of Q(0) can be estimated using the resampling
method via perturbation [Parzen, Wei and Ying (1994); Cai, Lin and Carroll
(2012)]. The perturbation method approximates the target distribution of
Q by generating random variables εˆ from the estimated asymptotic distri-
bution of ε. This perturbation procedure is also called the score-based wild
bootstrap [Kline and Santos (2012)].
Specifically, set εˆ = n−1/2
∑n
i=1U
T
i (Yi − µˆi)Ni, where Ni’s are indepen-
dent N(0,1). By generating independent N = (N1, . . . ,Nn) repeatedly, the
distribution of εˆ conditional on the observed data is asymptotically the same
as that of ε. Denoted by {Q̂(0)(b), b= 1, . . . ,B}, where B is the number of
perturbations, it follows that the empirical distribution of the Q̂(0)(b) is the
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same as that of Q(0) asymptotically. The p-value can be approximated using
the tail probability by comparing {Q̂(0)(b), b= 1, . . . ,B} with the observed
Q. Hence, one can calculate the p-values of QSGC , QSG and QS by set-
ting Vi = (
√
a1S
T
i ,
√
a2Gi,
√
a3C
T
i )
T , (
√
a1S
T
i ,
√
a2Gi) and
√
a1S
T
i and gen-
erate their perturbed realizations of the null counterpart as {Q̂SGC (0)(b)},
{Q̂SG(0)(b)} and {Q̂S(0)(b)}, and compare them with corresponding observed
values, respectively. Note that for each perturbation b, the random normal
perturbation variable N (b) is the same across the three tests such that the
correlation among QSGC , QSG and QS can be preserved.
The p-value of the omnibus test can be easily calculated using the pertur-
bation method. Let P̂S = SS(QS), P̂SG = SSG(QSG) and P̂SGC = SSGC (QSGC )
be the three p-values using the three statistics, where SS(q) = pr{Q̂S(0)(b) >
q}, SSG(q) = pr{Q̂SG(0)(b) > q} and SSGC (q) = pr{Q̂SGC (0)(b) > q}. The
null distribution of the minimum p-value, P̂min =min(P̂S , P̂SG, P̂SGC ), can
be approximated by P̂
(b)
min =min{SS(Q̂S(0)(b)), SSG(Q̂SG(0)(b)),SSGC (Q̂SGC (0)(b))}
(b= 1, . . . ,B). The p-value of the omnibus test hence can be calculated by
comparing the observed minimum p-value P̂min with its empirical null dis-
tribution {P̂ (b)min}.
Note that different from permutation where the observed data are shuffled
and resampled to calculate the test statistic Q, the perturbation procedure
resamples from the asymptotic null distribution of Q without recalculating
Q using the shuffled data. Thus, it is much more efficient than the permu-
tation method. Using a single CPU (2.53 GHz) to run 100 genes (each with
10 SNPs) and 100 cases/100 controls, the computation time is 134.10 and
809.76 seconds for the perturbation and permutation methods (both with
200 resampling), respectively. Furthermore, covariates can be easily adjusted
using the perturbation method, but covariate adjustment is more difficult
using permutation. Specifically, the permutation-based p-values calculated
by simply permuting SNPs and gene expression fail if SNPs/gene expression
are correlated with covariates.
4. Understanding the total effect of a gene and the assumptions of the
test using the causal mediation analysis framework.
4.1. Characterization of SNPs, gene expression and disease risk in the
framework of causal mediation modeling. To understand the null hypoth-
esis of no total effect of a gene captured by SNPs in a gene and a gene
expression and the underlying assumptions, we discuss in this section how
to interpret the null in (2.3) within the causal mediation analysis framework.
Causal interpretation can be helpful for understanding genetic etiology of
diseases as well as for applications in pharmaceutical research [Li et al.
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(2010)]. Although genotype is essentially fixed at conception, it is at that
time effectively randomized, conditional on parental genotypes, and could be
viewed as subject to have hypothetical intervention. The statistical problem
of jointly modeling a set of SNPs, a gene expression and a disease can be
presented as a causal diagram [Pearl (2001); Robins (2003)] in Figure 1 and
be framed using a causal mediation model [VanderWeele and Vansteelandt
(2009, 2010); Imai, Keele and Yamamoto (2010)] based on counterfactuals
[Rubin (1974, 1978)]. VanderWeele and Vansteelandt (2010) and Imai, Keele
and Yamamoto (2010) have used the causal mediation analysis for epidemio-
logical and social science studies, respectively, where the exposure of interest
is univariate.
One can decompose the total effect (TE) of SNPs into the Direct Effect
(DE) and the Indirect Effect (IE). The Direct Effect of SNPs is the effect
of the SNPs on the disease outcome that is not through gene expression,
whereas the Indirect Effect of the SNPs is the effect of the SNPs on the
disease outcome that is through the gene expression. Within the causal
mediation analysis framework, we derive in the supplementary material the
TE, DE and IE of the SNPs on the disease outcome [Huang, VanderWeele
and Lin (2013)].
Specifically, we define the total effect (TE) of SNPs as
TE= logit{P (Y = 1|S= s1,X)} − logit{P (Y = 1|S= s0,X)},
that is, the equation (2.1) marginalizes over gene expression G. In Section 1
of the supplementary material [Huang, VanderWeele and Lin (2013)], we
show that for rare diseases, the total effect of the SNPs on the log odds ratio
(OR) of disease risk can be expressed in terms of the regression coefficients
in models (2.1) and (2.2) and is approximately equal to
TE = (s1 − s0)T {βS + βGδ+ γ(xTφ+ sT0 δ + βGσ2G) + δsT1 γ}
(4.1)
+ 12σ
2
G(s1 + s0)
Tγ(s1 − s0)Tγ.
We can express the DE and IE of the SNPs on the log odds ratio of disease
risk in terms of the regression coefficients in models (2.1) and (2.2). For rare
diseases, they are, respectively, approximately equal to
DE = (s1 − s0)T [βS + γ(xTφ+ sT0 δ + βGσ2G)]
(4.2)
+ 12σ
2
G(s1 + s0)
Tγ(s1 − s0)Tγ,
IE = (s1 − s0)Tδ(βG + sT1 γ).(4.3)
These are derived in Section 1 of the supplementary materials using coun-
terfactuals under the assumptions of no unmeasured confounding [Huang,
VanderWeele and Lin (2013)].
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The sum of the direct and indirect effects is equal to the total effect of
the SNPs, that is, TE =DE+ IE. As shown in the supplementary material
[Huang, VanderWeele and Lin (2013)] and discussed in Section 3.2, identi-
fication of the total effect requires a much weaker assumption than those
required for the direct and indirect effects.
4.2. Understanding the null hypothesis for eQTL SNPs. Under the as-
sumption that the gene expression G is associated with the SNPs S (i.e.,
eQTL SNPs), that is, δ 6= 0, using equations (4.2) and (4.3), the test for the
joint effects of SNPs in a SNP set S and a gene expression G on Y , that
is, the total effect of a gene, is equivalent to a test for the total SNP effect
on the outcome (Y ). In fact, for eQTL SNPs, which have nonzero effects
on expression G (i.e., δ 6= 0), using the expressions of DE and IE in (4.2)
and (4.3), one can show that the null hypothesis of no direct and indirect
genetic (SNP) effects is equivalent to the null hypothesis (2.3) that all the
regression coefficients (βS , βG and γ) equal zero:
H0 :βS = 0, βG = 0, γ = 0 ⇔ H0 :DE = 0, IE = 0.
The null hypothesis (2.3) that all the regression coefficients (βS , βG and
γ) are equal to zero is also equivalent to the null hypothesis of no total effect
of the SNPs provided βS + βGδ 6= 0 if βS or βG is not 0 for eQTL SNPs
(δ 6= 0), that is,
H0 :βS = 0, βG = 0, γ = 0 ⇔ H0 :TE =DE+ IE= 0.(4.4)
We show in Section 1.4 of the supplementary material that the null hy-
pothesis (4.4) requires only the assumption of no unmeasured confounding
for the effect of eQTL SNPs (S) on the outcome (Y ) after adjusting for the
covariates (X) [Huang, VanderWeele and Lin (2013)]. Most genetic associ-
ation studies make this assumption. In other words, we make no stronger
assumption than standard SNP only analyses for testing the null hypothesis
of no total effect of the SNP set in a gene.
Note that in models (2.1) and (2.2) we allow other covariates (X) to affect
both the gene expression and the disease. If the covariates X affect both
expression and disease, ignoring X may cause confounding in estimating DE
and IE. As shown in Figure 1, if arrows fromX to G and Y exist andX is not
controlled for, assumption (2) in Section 1.2 of the supplementary material
is violated [Huang, VanderWeele and Lin (2013)]. But if the covariates X,
the common causes of expression and disease, do not affect the SNPs S (no
arrow from X to S), the estimation and hypothesis testing for TE is still
valid. However, if there does exist an effect of X on S, then it violates the
above assumption of no unmeasured confounding for the S–Y association
and, thus, the test or estimation for TE will be biased.
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4.3. Understanding the null hypothesis for non-eQTL SNPs. If SNPs
have no effect on gene expression (δ = 0), that is, they are not eQTL SNPs,
then there is no indirect effect of the SNPs on Y , so that the null hypothesis
of no total effect of a gene (H0 :βS = 0, βG = 0,γ = 0) is not equivalent
to testing for no total SNP effect on Y (H0 :TE = DE + IE = 0). In this
case, what the null hypothesis, H0 :βS = 0, βG = 0,γ = 0, tries to evaluate
is simply whether there exists a joint effect of the given set of SNPs S and the
given gene expression G, and possibly their interactive effect, on disease risk.
To test for such a joint effect, we need the first two assumptions regarding no
unmeasured confounding in Section 1.2 of the supplementary material: no
unmeasured confounding of the SNPs on the outcome and no unmeasured
confounding of the gene expression on the outcome [Huang, VanderWeele
and Lin (2013)].
4.4. Understanding the traditional genetic analysis using the SNP only
model. In standard genetic association analysis, we usually fit the following
SNP only model:
logit{P (Yi = 1|Si,Xi)}=XTi α∗ + STi β∗S ,(4.5)
which does not take gene expression into account, but simply considers the
association between the outcome and SNPs adjusting for covariates. Note
for the special case where SNP, S, is univariate, the model (4.5) corresponds
to single SNP analysis, the most common approach in GWAS. Kwee et al.
(2008) and Wu et al. (2010) have developed tests for a SNP-set for H0 :β
∗
S =
0 under (4.5), which can be more powerful than individual SNP tests for the
association between the joint effects of the SNPs in a gene and the outcome
by borrowing information across SNPs within a gene, especially when the
SNPs are in good linkage disequilibrium (LD).
Assuming the true models that depend on both SNPs and a gene ex-
pression are specified in (2.1) and (2.2), we study in this section how β∗S
in the misspecified standard SNP only model (4.5) is related to the re-
gression parameters βS, βG and γ in the true model (2.1) and what the
null hypothesis H0 :β
∗
S = 0 under (4.5) tests for. To focus on the funda-
mental issues and for simplicity, we first discuss the case of no interaction
effect between SNPs and gene expression on disease risk, that is, γ = 0 in
model (2.1). Under the true [Y |S,G,X] and [G|S,X] models in (2.1) and
(2.2) assuming no S×G interaction (γ = 0), by plugging (2.2) into (2.1),
the true [Y |S,G,X] model can be rewritten as logit{P (Yi = 1|Si,Xi, εi)}=
X
T
i (α + βGφ) + S
T
i (βS + βGδ) + βGεi. Integrating out εi ∼ N(0, σ2G), we
have the true [Y |S,X] model as
logit[P (Yi = 1|Si,Xi)]≈ c{XTi (α+ βGφ) +STi (βS + βGδ)},(4.6)
where c= (1+ 0.35× σ2Gβ2G)−1/2 [Zeger, Liang and Albert (1988)].
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A comparison of (4.5) with (4.6) shows that β∗S ≈ c(βS + βGδ) and that
the effect of S= s1 versus s0 on the outcome Y under the SNP only model
(4.5) corresponds to (s1 − s0)T {c(βS + βGδ)}, which is proportional to the
Total Effect of SNPs in (4.1) when γ = 0. It follows that testing for β∗S = 0
in the SNP only model (4.5) is approximately equivalent to testing for no
total effect of the SNPs.
However, if there exists a SNP-by-expression interaction on Y and the
SNPs are eQTL SNPs, the naive SNP only analysis using (4.5) does not
provide obvious correspondence to the total SNP effect. As shown in Sec-
tion 2 of the supplementary material [Huang, VanderWeele and Lin (2013)],
the induced true [Y |S,X] model in this setting follows
logit{P (Yi = 1|Si,Xi)}
(4.7)
≈ c∗i {XTi (α+φβG) +STi (βS + δβG) +XTi φSTi γ +STi δSTi γ},
where c∗i = {1+0.35σ2G(βG+STi γ)2}−1/2. This implies that if the [Y |S,G,X]
follows the interaction model (2.1), the induced true [Y |S,X] model de-
pends not only on the linear terms of X and S but also on the cross-product
terms of X and S and the second order term of S. A comparison of (4.5)
with (4.7) shows that the standard SNP only model (4.5) misspecifies the
functional form of the true [Y |S,X]. The test for H0 :β∗S = 0 under the
misspecified SNP only model (4.5) will still be valid for testing the to-
tal effects of SNPs, because under the null the two models are the same.
However, the misspecified model is subject to power loss, compared to the
test based on the correctly specified model. With only an interaction effect
(γ 6= 0, βS = 0, βG = 0), (4.7) can be written as logit[P (Yi = 1|Si,Xi)] ≈
c∗i {XTi α+XTi φSTi γ+STi δSTi γ}, where c∗i = {1+0.35σ2G(STi γ)2}−1/2. If we
assume this is the true model and fit the conventional GWAS model (4.5) to
test for the SNP effect, the test is again still valid under the null, but loses
power under the alternative.
4.5. Understanding the relation with Mendelian randomization. The ap-
proach here differs in several ways from that based on Mendelian randomiza-
tion [Smith and Ebrahim (2003 and 2005)] in which genetic markers (SNPs)
are instrumental variables to assess the effect of an exposure (in our case,
a gene expression value) on an outcome. Here we are interested in using a
gene expression to increase power for testing for the total effect of SNPs
on a disease outcome. Furthermore, Mendelian randomization makes the as-
sumption that SNPs do not have an effect on an outcome except through an
exposure (e.g., gene expression in our case), in other words, no direct effect.
No such assumption is being made here. This is because we are interested
in testing for a different effect, that is, the effect of SNPs, rather than the
effect of an exposure (gene expression) on disease risk.
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5. Simulation studies.
5.1. Simulation setup. To make the simulation mimic the motivating
asthma data [Moffatt et al. (2007)], we simulated data using the ORMDL3
gene on chromosome 17q21. We generated the SNP data in the ORMDL3
gene by accounting for its linkage disequilibrium structure using HAPGEN
based on the CEU sample [Marchini et al. (2007)]. The genomic location used
to generate the SNP data is between 35.22 and 35.39 Mb on chromosome
17, which contains 99 HapMap SNPs. Ten of the 99 HapMap SNPs are
genotyped on the Illumina HumanHap300 array, that is, 10 typed SNPs.
To generate gene expression and the disease outcome, we assumed there
is one causal SNP Scausal and varied the causal SNP among the 99 HapMap
SNPs in each simulation. In Section 5.4 we further perform a simulation
study assuming three causal SNPs. For subject i, gene expression Gi was
generated by the linear regression model Gi = 0 + δ × Scausal,i + εi, εi ∼
N(0,1.44). The outcome Yi was generated by the logistic model
logit{P (Yi = 1|Scausal,i,Gi)}
=−0.2 + βS × Scausal,i + βG ×Gi + γ ×GiScausal,i.
The parameters and the range of βS , βG and γ were based on the empirical
estimates from analysis of the asthma data. For each simulation, we first
generated a cohort with 1000 subjects, and 100 cases and 100 controls were
randomly selected from the 1000 subjects to form a case–control sample.
Two sets of simulations were performed. In the first set, we selected the
SNP rs8067378 as the causal SNP, as this SNP is highly associated with
asthma in the original GWAS [Moffatt et al. (2007)]. For each configuration
of βS , βG, γ and δ, we generated 2000 data sets to calculate the empirical
size and power. In the second set of simulation, the causal SNP was cho-
sen one at a time out of the 99 HapMap SNPs. For each selected causal
SNP, we generated 1000 data sets and evaluated statistical power for two
different disease models: (βS , βG, γ) = (0.4,0,0) or (0.2,0.2,0). In both sim-
ulation settings, we used the 10 typed SNPs of the ORMDL3 gene on the
Illumina chip to form the SNP-set for the model (2.1), that is, p = 10, in
calculating the test statistics QS , QSG, QSGC and the omnibus test. For
QSG and QSGC , both weighted and unweighted methods were investigated,
where a1 = 1, a2 = (IG/IτS )
−1/2 and a3 = (IτI/IτS )
−1/2 for the weighted
statistic, and a1 = a2 = a3 = 1 for the unweighted statistic. The p-values
were calculated using the scaled χ2 approximation, the Davies’ method by
inverting the characteristic function [Davies (1980)] and the perturbation
procedure with 500 perturbations. The results of these approximations were
very similar at the significance level of 0.05. We performed the omnibus test
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by combining the evidence from QS , weighted QSG and weighted QSGC .
5.2. Size and power: By varying effect sizes for a fixed causal SNP. We
first evaluated the sizes of the proposed score tests, where the null distribu-
tion was approximated by either the scaled χ2 approximation or the pertur-
bation procedure (Table 1). Type I errors are well protected using both ap-
proximation methods under the three models with statistics QS ,QSG,QSGC .
The empirical size is close to 0.05 for the omnibus test and the three models.
As the results using different approximation methods are similar at the level
of 0.05, we only present in the following the empirical power using the per-
turbation method. We also evaluate the performance of the proposed tests
using the characteristic function inversion method [Davies (1980)] and the
perturbation method at smaller sizes (α= 5× 10−3 and 5× 10−4) (Table 1
of the supplementary material [Huang, VanderWeele and Lin (2013)]), and
find the methods perform well.
We assumed rs8067378 is the causal SNP and eQTL, and compared the
powers of the three statistics QS , QSG and QSGC as well as the omnibus
test under three different configurations of effect sizes (Figure 2). The first
setting assumes both gene expression and the interactions between the SNPs
and the gene expression have no effect on the outcome (βG = 0 and γ =
0) [Figure 2(a)]. As expected, QS shows the optimal power as it correctly
specifies the model. The other two tests QSG and QSGC , especially QSGC ,
over-specify the model and waste DF for testing the effects of expression
and interactions, and hence lose power. The performance of the omnibus
test is close to the QS . As a note, the correctly specified model here means
Table 1
Empirical sizes (%) of the proposed tests using scaled χ2 approximation and the
perturbation. The size was calculated at the significance level of 0.05 based on 2000
simulations
Scaled χ2 approximation Perturbation
Unweighted Weighted Unweighted Weighted
Gene expression depends on SNPs
SNPs 4.65 4.90
SNPs and expression 4.80 4.95 4.80 4.80
SNPs, expression and interaction 4.75 4.60 4.60 4.35
Omnibus test – 5.15
Gene expression and SNPs are independent
SNPs 4.83 4.97
SNPs and expression 4.87 4.90 4.83 4.87
SNPs, expression and interaction 4.60 4.80 4.77 5.07
Omnibus test – 5.13
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(a) βG = 0, γ = 0; δ = 1.0 (b) βG = 0.2, γ = 0; δ = 1.0
(c) βG = 0.2, γ = 0.2; δ = 1.0
Fig. 2. Empirical power. SNPs are assumed to be eQTL SNPs (δ = 1). Each figure plots
the powers of the proposed tests as a function of the main effect of the SNP (βs). The three
figures correspond to the three different true models, the model with only SNP effects, the
model with main effects without interaction and the model with SNPs, gene expression and
their interaction effects. The dashed line in (a) indicates 5% type I error rate.
that gene expression or nonlinear interaction has been incorporated in the
analyses, not that typed SNPs are causal.
The second setting assumes the gene expression has an effect on the out-
come but there is no interaction (βG = 0.2 and γ = 0) [Figure 2(b)], while
the third setting further assumes an interaction effect (βG = 0.2 and γ = 0.2)
[Figure 2(c)]. The tests QSG and QSGC , respectively, have the best power
under the correct model. In contrast to the setting 1, QS has the worst per-
formance among the three tests when expression has an effect on disease,
and the power loss of QS is even more in the presence of the interactions
[Figure 2(c)]. The unweighted QSG also does not perform well in these two
cases and has considerable loss of power. The rest of the tests have similar
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power. The performance of the omnibus test in both settings is close to the
optimal test with only minimal loss of power.
We also study in Figure 2 the performance of the likelihood ratio test
(LRT) for testing for the joint effects of SNPs and gene expression by com-
paring the model with an intercept, SNPs, gene expression and interactions
with the model with only the intercept. In general, our proposed methods
outperform the LRT in both power and type I error. The power loss and
the incorrect size of the LRT are likely due to the large degrees of freedom
relative to the sample size (DF = 21; 100 cases/100 controls) and the high
LD among some of the typed SNPs.
5.3. Power: By varying causal SNPs. In order to investigate the perfor-
mance under “synthetic association,” that is, the causal variant is untyped
(i.e., not on a chip) [Dickson et al. (2010)], we assessed the power of the
methods when each of the 99 HapMap SNPs was assumed to be causal.
In particular, we were interested in evaluating how the correlation between
the causal SNP and the 10 typed SNPs affected the statistical powers of
the proposed tests. Intuitively, if the causal SNP is untyped and has low
LD with the typed SNPs, one would expect lower power. We considered
two settings: the outcome is only associated with the causal SNP: βS = 0.4,
βG = 0, γ = 0 [Figure 3(a)]; and the outcome is associated with the causal
SNP and the gene expression but not their interaction: βS = 0.2, βG = 0.2,
γ = 0 [Figure 3(b)]. A total of 1000 simulations were performed.
Figures 3(a) and (b) show that the pattern of simulation results is very
similar to those in the previous section. The test assuming the correct model
performs the best. The omnibus test nearly reaches the optimal power ob-
tained under the true model in both settings. In addition, the test using
the weighted statistic derived under the model with SNPs and gene expres-
sion as predictors (weighted QSG) performs well even when the interaction
model is true (data not shown), although it has some loss of power in set-
ting 1 when only SNPs are associated with the outcome. As the model (2.1)
can be written as logit[P (Yi = 1|Si,Gi,Xi)] =XTi α+ STi β∗ +GiβG where
β∗ = βS+Giγ, the main effect only analyses can still capture the interactive
effect γ even though the model is not correctly specified. So the simpler test
QSG can be used as an alternative to the omnibus test if the computation
cost is a concern.
Figure 3 also shows that statistical power depends on the correlation
between the causal SNP (which might be untyped) and the 10 typed SNPs.
The power rises as the correlation between the causal SNP and the typed
SNPs increases. For example, the statistical power is high if a causal SNP
is in the LD block spanned between the second to the third typed SNPs
(marked as the second and third black triangles from left to right, according
to the physical location, in Figure 3), as it has good correlation with the
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(a) βS = 0.4, βG = 0, γ = 0
(b) βS = 0.2, βG = 0.2, γ = 0
Fig. 3. Simulated power curves for evaluating how different choices of causal SNPs af-
fect the powers of the proposed tests. The x-axis indicates the physical location (Mb) of
the 99 HapMap SNPs at 17q21. The orange vertical bar indicates the relative locations of
the causal SNP and the black triangles indicate the ten typed SNPs. Different lines indi-
cate the power of different tests. The lower panel of each subfigure is the plot for linkage
disequilibrium, measured as r2 ranging from 0 (white) to 1 (black).
typed SNPs. The power is generally low if a causal variant lies in the region
between the first and second typed SNPs, as it has little correlation with
the typed SNPs. In this case, it is virtually not possible to detect genetic
effects using the typed SNPs on the chip no matter what method one uses.
Although the typed SNPs might not include the underlying causal SNPs,
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it still provides a valid testing procedure due to the same model under the
null. However, the typed SNPs may or may not provide a consistent estimate
for the effect of the causal SNP, depending on the LD pattern of the causal
SNP and the typed SNPs.
5.4. Additional simulations: Model misspecification, multiple causal vari-
ants, varying LD structures. We performed additional simulations to assess
how model misspecification influences our proposed test. Gene expression
(a) βG = 0, γ = 0; δ = 1.0 (b) βG = 0, γ = 0; δ = 1.0
(c) βG = 0.2, γ = 0; δ = 1.0 (d) βG = 0.2, γ = 0; δ = 1.0
Fig. 4. Empirical power under model misspecification. SNPs are assumed to be
eQTL SNPs (δ = 1). Each figure plots the powers of the proposed tests as a func-
tion of the main effect of SNP (βs). The six figures correspond to the different true
models: the model with only SNP effects [ (a) and (b)], the model with main effects
of SNP and gene expression [ (c) and (d)] and the model with SNPs, gene expres-
sion and their interaction effects [ (e) and (f)]. (a), (c), (e) are simulated under
logit[P (Yi = 1|Scausal,i,Gi)] = −100
0.9 + (100 + βSScausal,i + βGGi + γGiScausal,i)
0.9
and (b), (d), (f) are simulated under the probit model
Φ−1[P (Yi = 1|Scausal,i,Gi)] = −0.2 + βSScausal,i + βGGi + γGiScausal,i. The dashed
lines in (a) and (b) indicate 5% type I error rate.
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(e) βG = 0.2, γ = 0.2; δ = 1.0 (f) βG = 0.05, γ = 0.15; δ = 1.0
Fig. 5. (Continued).
Gi was generated without the normality assumption Gi = 0+ δScausal,i+ εi,
εi ∼N(0,1.44)+uniform(−0.3,0.3). Two outcome models are explored. The
first model generates the outcome Yi by the logistic model assuming nonlin-
ear effects of SNPs and G as logit{P (Yi = 1|Scausal,i,Gi)}=−1000.9+(100+
βSScausal,i + βGGi + γGiScausal,i)
0.9, and the second model generates Yi by
a probit model Φ−1{P (Yi = 1|Scausal,i,Gi)} = −0.2 + βSScausal,i + βGGi +
γGiScausal,i. Although the model is not correctly specified in our proposed
test under these settings, the joint analyses of SNPs and expression still out-
perform the SNP-only analyses when the gene expression contributes to the
risk of developing disease. Similarly, the performance of the omnibus test is
very close to the optimal test obtained under the true model for different
scenarios (Figure 4).
We conducted two additional simulation studies by varying the number
of causal variants and LD structures. The pattern of the results from these
additional studies is very similar to what is presented above (Figures 1 and 2
in the supplementary material [Huang, VanderWeele and Lin (2013)]). The
first additional study is similar to the study in Section 5.2, except that there
are three causal SNPs in the ORMDL3 gene instead of a single causal SNP.
Using the same ten typed SNPs for the analyses, we again found that the
test performs the best when the model is correctly specified and the omnibus
test approaches the optimal test obtained under the true model with limited
power loss (Figure 1 of the supplementary material [Huang, VanderWeele
and Lin (2013)]).
Similar to analyses in Section 5.3, the second additional study investigates
the performance of the proposed test at 15q24–15q25.1, where SNPs have
a different LD pattern from the ORMDL3 gene. Assuming one causal SNP
at a time, we used the same ten typed SNPs to perform our proposed test.
Again, the test performs the best when the model is correctly specified, and
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the omnibus test is robust and approaches the optimal test obtained by
assuming the true model, and the power depends on the correlation of the
causal SNP and the typed SNPs (Figure 2 of the supplementary material
[Huang, VanderWeele and Lin (2013)]).
6. Analysis of the asthma data. We applied the proposed testing proce-
dures to reinvestigate the genetic effects of the ORMDL3 gene on the risk
of childhood asthma in the MRC-A data [Dixon et al. (2007); Moffatt et al.
(2007)]. This subset of the data contained 108 asthma cases and 50 controls
where we have complete data of the 10 typed SNPs and gene expression
of ORMDL3. The SNP data were genotyped using the Illumina 300K chip
and the gene expression was collected using the Affymetrix Hu133A 2.0. We
analyzed the data using both additive and dominant modes: in the additive
mode, the genotype was coded as the number of the minor allele (i.e., 0, 1,
2), whereas in the dominant mode, the genotype was coded as whether or
not the minor allele was present (i.e., 0, 1).
We applied the proposed tests for the total SNP effect of ORMDL3 using
the SNP and gene expression data. There are strong associations between
the SNPs and the gene expression (8 out of 10 with p-value< 0.05 and the
other two with p-values of 0.076 and 0.21), that is, the SNPs are eQTL SNPs.
We considered six test statistics: QS , unweighted QSG, weighted QSG, un-
weighted QSGC , weighted QSGC , and omnibus test (Table 2). We compared
our methods with the standard multivariate or univariate methods: the mul-
tivariate Wald test, which has 10, 11 and 21 degrees of freedom under the
three models (SNPs only, SNPs and gene expression, and SNPs, gene ex-
pression and interactions). We also included in the comparison the test using
Table 2
p-values of the effects of the 10 typed SNPs at ORMDL3 on the risk of childhood asthma.
Different rows indicate the predictors to be tested. Pmin calculates the minimum p-value
using individual SNP analyses; VCT is the proposed variance component test
Multivariate Bonferroni- Permutation- VCT VCT
Wald adjusted Pmin adjusted Pmin unweightedweighted
Additive model
SNPs 0.122 0.102 0.039 0.044
SNPs, gene 0.342 0.194 0.057 0.039 0.033
SNPs, gene and interaction 0.013 0.303 0.093 0.0025 0.0028
Omnibus test – 0.0055
Dominant model
SNPs 0.018 0.015 0.018 0.0045
SNPs, gene 0.094 0.031 0.018 0.0040 0.0040
SNPs, gene and interaction 0.131 0.098 0.048 0.0035 0.0023
Omnibus test – 0.0030
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the smallest p-value from the 10 single SNP analyses with the Bonferroni
adjustment or the adjustment using the permutation procedure to account
for the correlation among the SNPs.
The results in Table 2 show that our proposed methods give smaller p-
values compared to the standard testing procedures. The test QSGC , which
accounts for the effects of SNPs, gene expression and their interactions, gives
the smallest p-value compared to the tests only using SNPs, in both additive
and dominant modes. For example, the p-values using weighted QSGC and
QS are 0.0028 and 0.044, respectively, using the additive SNP model. The
omnibus test calculated using the perturbation procedure by computing the
minimum p-value from QS , weighted QSG and weighted QSGC also provides
a more significant signal than those only considering SNPs, with the p-value
being 0.0055. These results are consistent with the findings in simulation
studies.
We also performed genome-wide analyses for both SNP-sets and single
SNP. We first paired eQTL SNPs with their corresponding gene expression
[Dixon et al. (2007)] and performed SNP-only analyses and our proposed
method. For single SNP analyses, after adjustment of multiple comparison
using false discovery rate [FDR; Storey (2002)], 56 SNPs with FDR < 0.1
were identified in SNP-only analyses and 97 SNPs were identified from the
proposed omnibus test. For SNP-set analyses, we grouped eQTL SNPs that
correspond to the same gene as a SNP-set, and we identified 5 and 15 SNP-
sets (FDR< 0.1) from SNP-only analyses and omnibus tests, respectively.
7. Discussion. We proposed in this paper to integrate SNP and gene ex-
pression data to improve power for genetic association studies. The major
contributions of this paper are as follows: (1) to formulate the data inte-
gration problem of different types of genomic data as a mediation problem;
(2) to propose a powerful and robust testing procedure for the total effect
of a gene contributed by SNPs and a gene expression; and (3) to relax the
assumptions required for mediation analyses in the test for the total effect.
Specifically, as shown in Figure 1, we are able to integrate the information
of SNPs and gene expression as a biological process through the mediation
model. Our proposed variance component score test for the total effect of
SNPs and a gene expression circumvents the instability of estimation of the
joint effects of multiple SNPs and gene expression, because only the null
model needs to be fit. Mediation analysis to estimate direct and indirect
effects generally requires additional unmeasured confounding assumptions,
and previous work mainly focused on estimation. Here we focus on testing
for the total effect of a gene using SNPs and a gene expression. For eQTL
SNPs, we show that the total effect of a gene contributed by SNPs and a
gene expression is equivalent to the total effect of SNPs, which is the sum
of direct and indirect effects of SNPs mediated through gene expression.
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Testing for the total SNP effect only requires one assumption: no unmea-
sured confounding for the effect of SNPs on the outcome, which is the same
assumption as the standard GWAS and, thus, no stronger assumption is
required.
We characterize the relation among SNPs, gene expression and disease
risk in the framework of causal mediation modeling. This framework allows
us to understand the null hypothesis of no total effect of a gene contributed
by SNPs and gene expression, and the underlying assumptions of the test
for both eQTL SNPs and non-eQTL SNPs. We propose a variance compo-
nent score test for the total effects of a gene on disease. This test allows to
jointly test for the effects of SNPs, gene expression and their interactions. We
showed that the proposed test statistic follows a mixture of χ2 distributions
asymptotically, and proposed to approximate its finite sample distribution
using a scaled χ2 distribution, a characteristic function inversion method or
a perturbation method.
We considered three tests: using only SNPs (QS), SNPs and gene expres-
sion main effects (QSG), and SNPs, gene expression and their interactions
(QSGC ). Our simulation study shows that all three tests have the correct
type I error for testing for the overall SNP effect. The relative power of these
tests depends on the underlying true relation between the predictors (SNPs,
gene expression and their interactions) and disease. As the underlying biol-
ogy is often unknown, we further constructed the omnibus test that identifies
the most powerful test among the three disease models, and proposed to use
the perturbation method to calculate the p-value for the omnibus test. Fur-
ther, the test using only the main effects of SNPs and gene expression loses
limited power compared to the omnibus test and can be used as a simple
alternative.
Our results also show that to test for the total effects of a gene, the tests
that incorporate both SNP and gene expression information, such as QSG
and QSGC , are more powerful if SNPs are associated with gene expression
than if they are not. In other words, it is even more beneficial to incorporate
gene expression data with SNP data to detect genetic effects on disease if
gene expression is a good causal mediator for the SNPs. To achieve this,
a natural way is to select SNPs located within or at the neighborhood of
a gene, since it has been well destablished that the SNP within a gene
can alter its expression value via transcription regulation [Lee and Shatkay
(2008)]. Alternatively, one can restrict the joint SNP-expression analysis
to known eQTL SNPs. If selection of eQTL SNPs is based on statistical
significance, one also needs to be aware of the possibility that cis-action may
be a confounding effect of SNPs on array hybridization [Li et al. (2006)].
We mainly focus on testing for the total effect of a gene in this paper.
The proposed method can be easily extended to test for direct and indirect
effects separately for eQTL SNPs. Using equation (4.2), to test for the direct
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effect of the SNPs, one can test H0 :βS = 0,γ = 0. Using the notation in
equation (3.2), one can test this null hypothesis using the statistic QDE =
n−1(a1UτS + a3UτI ), where the null model is a logistic model with X and
G. To test for the indirect effects of the SNPs, using equation (4.3), one can
test H0 :βG = 0,γ = 0. Using the notation in equation (3.2), one can test
this null hypothesis using the statistic QIE = n
−1(a2U
2
βG
+a3UτI ), where the
null model is a logistic model with X and S. As the number of SNPs S
might be large and some SNPs might be highly correlated (with high LD),
standard regression to fit the null model might not work well. One can fit the
null model using ridge regression. To perform these tests, one will need to
make the four unmeasured confounding assumptions required for estimating
direct and indirect effects of SNPs stated in Section 1.2 of the supplementary
material [Huang, VanderWeele and Lin (2013)].
Gene expression may not be the only mediator for the relation between
SNPs and disease. Other biomarkers, such as DNA methylation, proteins,
metabolites of the gene product in the blood, immunological or biochemical
markers in the serum, and environmental factors can also serve as poten-
tial mediators, depending on the context or the disease to be studied. For
instance, epigenetic variations have been reported to exert heritable phe-
notypic effects [Johannes, Colot and Jansen (2008)]. Furthermore, our pro-
posed test can be applied to address many other scientific questions as long
as there exists a causal relationship as illustrated in Figure 1. For example,
the SNP-gene-disease relations can be replaced by the DNA copy number-
protein-cancer stage (early vs. late) in tumor genomics studies to assess if
copy number can have any effect on the clinical stage of cancer. It is ad-
vantageous to set up a biologically meaningful model before applying our
proposed test procedure, which makes the best use of the prior knowledge.
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SUPPLEMENTARY MATERIAL
Detailed causal and statistical development and supplementary table and
figures (DOI: 10.1214/13-AOAS690SUPP; .pdf). Section 1: detailed devel-
opment of causal mediation model and derivations referenced in Sections 4.1
and 4.2; Section 2: derivation of model (4.7) in Sections 4.4; Section 3:
asymptotic distribution of Q referenced in Section 3.1; table and figures
referenced in Sections 5.2 and 5.4.
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